3

OWNERSHIP DOCUMENT

Company: ADIAL PHARMACEUTICALS, INC.
Filed: July 26, 2018
Period of Report: July 26, 2018
Accession Number: 0001213900-18-009722

View Document ↗ View on SEC.gov ↗